Journals / Journal of Urological Surgery / 2021 / Cilt: 8 - Sayı: 2

Changes That Have Occurred in the Surgical Treatment Preference for Non-emergent Kidney Stones During the COVID-19 Pandemic: Six Months of Clinical Experience in A Tertiary Referral Centre

Pages
86–91
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Moreover, interruption of the residents’ surgical training secondary to thedecreasing number of cases is one of the pandemic’s critical drawbacks.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Owing to the outbreak of the coronavirus disease-2019 (COVID-19), treatment approaches are reshapened because of the excessive loadon the health system.
📊
Key Findings & Data:This study aimed to investigate the differences in our surgical approach to kidney stone cases between the COVID-19 periodand pre-COVID-19 period.Materials and Methods: Patients who underwent retrograde intrarenal surgery (RIRS) or percutaneous nephrolithotripsy (PNL) for kidney stonesin our clinic between March 11, 2020, and September 11, 2020, and those in the same period 1 year ago were included in the study.
💡
Conclusion & Impact:Moreover, interruption of the residents’ surgical training secondary to thedecreasing number of cases is one of the pandemic’s critical drawbacks.
🔬Design:Research Article
📍Scope:2019 Verileri
⚙️Variables:Domain Parameters

Özet

Objective: Owing to the outbreak of the coronavirus disease-2019 (COVID-19), treatment approaches are reshapened because of the excessive loadon the health system. This study aimed to investigate the differences in our surgical approach to kidney stone cases between the COVID-19 periodand pre-COVID-19 period.Materials and Methods: Patients who underwent retrograde intrarenal surgery (RIRS) or percutaneous nephrolithotripsy (PNL) for kidney stonesin our clinic between March 11, 2020, and September 11, 2020, and those in the same period 1 year ago were included in the study. Demographicinformation, laboratory data, stone characteristics, treatment choices and results were evaluated comparatively.Results: A total of 39 patients in the COVID-19 period (group 1) and 93 patients in the pre- COVID-19 period (group 2) underwent kidney stonesurgery. While RIRS was performed to 32 of the patients in group 1, PNL was applied to seven of the patients in group 2. RIRS was performed to 70patients in group 2, and PNL was applied to 23 of them. While the RIRS/PNL ratio was 4.5 in group 1, it was 3.04 in group 2. During the COVID-19period, the number of patients who underwent PNL has decreased significantly.Conclusion: The number of elective surgery cases has significantly decreased during the COVID-19 pandemic. It is predicted that the incidence oforgan loss will increase due to complications and delayed treatment. Moreover, interruption of the residents’ surgical training secondary to thedecreasing number of cases is one of the pandemic’s critical drawbacks.

🔖

Cite This Article

BATUR, A. F., GÜLMEN, M., BÖCÜ, K., GÜL, M., KAYNAR, M., KILIÇ, Ö., GÖKTAŞ, S. (2021). Changes That Have Occurred in the Surgical Treatment Preference for Non-emergent Kidney Stones During the COVID-19 Pandemic: Six Months of Clinical Experience in A Tertiary Referral Centre. Journal of Urological Surgery, Cilt: 8 - Sayı: 2, 86–91. https://ajindex.com/articles/347510

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Türk C, Neisius A, Petrik A, Seitz C, Skolarikos A, Thomas K. EAU Guidelines on Urolithiasis. European Association of Urology 2018;69:475-482
  2. Karagöz MA, Erihan IB, Doluoğlu ÖG, Uğurlu Ç, Bağcıoğlu M, Uslu M, Sarıca K. Efficacy and safety of fURS in stones larger than 20 mm: is it still the threshold? Cent European J Urol 2020;73:49-54
  3. Palmero JL, Durán-Rivera AJ, Miralles J, Pastor JC, Benedicto A. Comparative study for the efficacy and safety of percutaneous nefhrolithotomy (PCNL) and retrograde intrarenal surgery (RIRS) for the treatment of 2-3,5 cm kidney stones. Arch Esp Urol 2016;69:67-72
  4. Jee Y. WHO International Health Regulations Emergency Committee for the COVID-19 outbreak. Epidemiol Health 2020;42:2020013
  5. McCloskey B, Zumla A, Ippolito G, Blumberg L, Arbon P, Cicero A, Endericks T, Lim PL, Borodina M; WHO Novel Coronavirus-19 Mass Gatherings Expert Group. Mass gathering events and reducing further global spread of COVID-19: a political and public health dilemma. Lancet 2020;395:1096- 1099
  6. Ribal MJ, Cornford P, Briganti A, Knoll T, Gravas S, Babjuk M, Harding C, Breda A, Bex A; GORRG Group, Rassweiler JJ, Gözen AS, Pini G, Liatsikos E, Giannarini G, Mottrie A, Subramaniam R, Sofikitis N, Rocco BMC, Xie LP, Witjes JA, Mottet N, Ljungberg B, Rouprêt M, Laguna MP, Salonia A, Bonkat G, Blok BFM, Türk C, Radmayr C, Kitrey ND, Engeler DS, Lumen N, Hakenberg OW, Watkin N, Hamid R, Olsburgh J, Darraugh J, Shepherd R, Smith EJ, Chapple CR, Stenzl A, Van Poppel H, Wirth M, Sønksen J, N’Dow J; EAU Section Offices and the EAU Guidelines Panels. European Association of Urology Guidelines Office Rapid Reaction Group: An Organisationwide Collaborative Effort to Adapt the European Association of Urology Guidelines Recommendations to the Coronavirus Disease 2019 Era. Eur Urol 2020;78:21-28
  7. Türk C, Knoll T, Petrik A, Sarica K, Skolarikos A, Straub M, Seitz C. Guidelines on urolithiasis. Eur Assoc Urol 2015
  8. Heinze A, Umari P, Basulto-Martínez M, Suárez-Ibarrola R, Liatsikos E, Rassweiler J, Guven S, Gözen AS. Impact of COVID-19 on Clinical and Academic Urological Practice: A Survey from European Association of Urology Section of Uro-technology. Eur Urol Open Sci 2020;21:22-28
  9. Serrano OK, Orlando R, Papasavas P, McClure MH, Kumar A, Steinberg AC, Cohen JL, Shichman SJ, Singh RK, Sardella WV, Schipper BM. Getting back to work: A framework and pivot plan to resume elective surgery and procedures after COVID-19. Surg Open Sci 2021;4:1